Effectiveness of josamycin in SARS in newborn and infant children

Shavazi , Nurali, Ibragimova , Marina, Шавази , Нурали, Ибрагимова , Марина, Shavazi , Nurali, Ibragimova , Marina

Халқаро илмий педиатрия журнали · 2023-yil

Annotatsiya

Annotation. Pneumonia is one of the most common diseases that occupies a leading place in the structure of morbidity and mortality from infectious diseases in children, manifested by symptoms of respiratory failure. We treated him with an antibacterial drug - josamycin. The aim of the work is to study the effectiveness of the use of the drug Josamycin in atypical pneumonia in children. Materials and methods of research: depending on the prescribed therapy, we treated 60 patients aged 3 to 10 years, who were divided into 2 groups. The patients were hospitalized in the Samarkand Branch of the Republican Scientific Center for Emergency Medical Care, in the departments of pediatrics. 30 patients were prescribed Josamycin at the age dosage for 10 days. Clinical manifestations of group I, who received the drug Josamycin stopped almost 2 times faster, compared with patients from group II. The use of Josamycin in SARS has shown that it is an effective drug that prevents and reduces the severity of pneumonia.

Maqola ma’lumotlari
MualliflarShavazi , Nurali, Ibragimova , Marina, Шавази , Нурали, Ибрагимова , Марина, Shavazi , Nurali, Ibragimova , Marina
JurnalХалқаро илмий педиатрия журнали
NashriyotАндижон давлат тиббиёт институти; In Science МЧЖ
ISSN2181-2926, 2181-2926
Nashr sanasi2023-02-28
Jild2
Son2
Betlar44-46
TilIngliz
Ilmiy sohaTibbiyot
DOI10.56121/2181-2926-2023-2-2-44-46
Indeksga qo‘shilgan2026-08-26

DOI: 10.56121/2181-2926-2023-2-2-44-46 · Maqolaning asl sahifasi

Kalit so‘zlar

лечение, атипичная пневмония, Джозамицин, дети, atypical pneumonia, Josamycin, children, davolash, atipik pnevmoniya, Josamitsin, bolalar

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAShavazi , Nurali, Ibragimova , Marina, Шавази , Нурали, Ибрагимова , Марина, Shavazi , Nurali, & Ibragimova , Marina (2023). EFFECTIVENESS OF JOSAMYCIN IN SARS IN NEWBORN AND INFANT CHILDREN. Халқаро илмий педиатрия журнали, 2(2), 44-46. https://doi.org/10.56121/2181-2926-2023-2-2-44-46
GOST (OAK)Shavazi , Nurali va b. EFFECTIVENESS OF JOSAMYCIN IN SARS IN NEWBORN AND INFANT CHILDREN // Халқаро илмий педиатрия журнали. – 2023. – T. 2, № 2. – P. 44-46. – DOI: 10.56121/2181-2926-2023-2-2-44-46.
MLAShavazi , Nurali, Ibragimova , Marina, Шавази , Нурали, Ибрагимова , Марина, Shavazi , Nurali, and Ibragimova , Marina. “EFFECTIVENESS OF JOSAMYCIN IN SARS IN NEWBORN AND INFANT CHILDREN.” Халқаро илмий педиатрия журнали, 2(2), 44-46, 2023. https://doi.org/10.56121/2181-2926-2023-2-2-44-46
ChicagoShavazi , Nurali, Ibragimova , Marina, Шавази , Нурали, Ибрагимова , Марина, Shavazi , Nurali, and Ibragimova , Marina. “EFFECTIVENESS OF JOSAMYCIN IN SARS IN NEWBORN AND INFANT CHILDREN.” Халқаро илмий педиатрия журнали, 2(2), 44-46 (2023). https://doi.org/10.56121/2181-2926-2023-2-2-44-46
HarvardShavazi , Nurali, Ibragimova , Marina, Шавази , Нурали, Ибрагимова , Марина, Shavazi , Nurali, and Ibragimova , Marina (2023) ‘EFFECTIVENESS OF JOSAMYCIN IN SARS IN NEWBORN AND INFANT CHILDREN’, Халқаро илмий педиатрия журнали, 2(2), 44-46. https://doi.org/10.56121/2181-2926-2023-2-2-44-46
BibTeX
@article{shavazinurali2023,
  title = {EFFECTIVENESS OF JOSAMYCIN IN SARS IN NEWBORN AND INFANT CHILDREN},
  author = {Shavazi , Nurali and Ibragimova , Marina and Шавази , Нурали and Ибрагимова , Марина and Shavazi , Nurali and Ibragimova , Marina},
  journal = {Халқаро илмий педиатрия журнали},
  year = {2023},
  volume = {2},
  number = {2},
  pages = {44-46},
  doi = {10.56121/2181-2926-2023-2-2-44-46},
  url = {https://doi.org/10.56121/2181-2926-2023-2-2-44-46}
}

Boshqa maqola uchun iqtibos tayyorlash

Халқаро илмий педиатрия журнали jurnalidan boshqa maqolalar

Халқаро илмий педиатрия журнали — barcha maqolalar · 2023-yil arxivi

Shavazi , Nurali — boshqa maqolalari

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari